13 Jul 2018 4 min read

Will our children live longer than us?

By James Carrick

For decades, demographers were too pessimistic on life expectancy and had to revise up their forecasts. Are they now too optimistic? Recent data suggest that UK ‘death rates’ have stopped improving. If sustained, life expectancy projections would need to be revised down. This would have profound implications for government and pension finances.

UK life expectancy has been rising for the past 150 years. Initial gains were concentrated in childhood survival rates. But the life expectancy of adults (i.e. those who had already survived childhood) also improved from the turn of the 20th century.

So – on average – we’re used to each generation living longer than the previous one. For example: our grandparents living longer than our great-grandparents.

Demographers did not anticipate these improvements.

The chart below plots how forecasts for UK male life expectancy have evolved over time. For example in 1975, demographers saw UK male life expectancy at 71 in 2011. In actual fact, it rose to 78 – a gap of 7 years.

Each successive forecast for life expectancy has been revised up (as shown by the lines shifting higher) – catching up with better-than-anticipated outturns.

But something has changed since 2012. The latest 2017 projections (dashed thick blue line) are LOWER than those made in 2012.

The SLOPE of the 2017 projection is similar to the slope of the 2012 forecast. That is to say: demographers continue to expect life expectancy to rise over time, but from a lower starting point than previously thought.

There are downside risks to this assumption: death rates are not improving.

The chart below shows that ‘death rates’ (mortality rates adjusted for the age-distribution of the population) stopped declining since the 2012 projections were made. They have broadly stabilised rather than continue the trend decline seen since the 1970s.


It’s unclear why this has happened, but there are a number of factors that warrant further investigation:

  • Its persistence throughout the years as well as seasonal data suggest it’s not due to ‘bad winter flu’.
  • Benefits of lower smoking rates could be dropping out
  • Obesity prevalence continues to rise
  • International peer comparisons are mixed: life expectancy is generally still rising, but at a slower pace. US life expectancy is falling
  • ‘Austerity’ is often blamed. As we have repeatedly shown, health-care needs are soaring as the population ages
  • The top quartile of society continues to improve – this could be because they are already healthier than average or because they have access to additional medical care

History shows how difficult it has been to forecast life expectancy and we don’t claim any advantage. New technologies are coming out: our Real Assets team recently highlighted innovations in social care. But the pressure on health budgets from an ageing population will continue.

All we do know is that the current demographic projections made by the Office for National Statistics (ONS) assume further declines in ‘death rates’. This leads to further increases in life expectancy.

The outlook is unclear. But if death rates and life expectancy do not improve as much as currently projected, there will be fewer pensioners than anticipated. This would have significant implications for pension schemes – both public and private – and investments (see this blog by our LDI team).

James Carrick

Global economist

James is a global economist with a knack for using analogies to explain economic concepts. He is a techno-optimist and an early adopter. He enjoys building models - both of the economy and robot Lego ones with his son. He also likes crunching data and chocolate bars. He joined in 2006 from the number-one ranked economics team at ABN AMRO with prior experience at HM Treasury.

James Carrick